|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 | |
| A61P 37/06 | |||
| G01N 33/53 | |||
| C07K 14/54 |
| (11) | Patento numeris | 2027157 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07786719.0 |
| Europos patento paraiškos padavimo data | 2007-05-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-02-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2007/055029 |
| Data | 2007-05-23 |
| (87) | Numeris | WO 2007/137984 |
| Data | 2007-12-06 |
| (30) | Numeris | Data | Šalis |
| 0610438 | 2006-05-25 | GB | |
| 0611046 | 2006-06-05 | GB |
| (72) |
ELLIS, Jonathan Henry, GB
GERMASCHEWSKI, Volker, GB
HAMBLIN, Paul Andrew, GB
KIRBY, Ian, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | MODIFIED HUMANISED ANTI-INTERLEUKIN-18 ANTIBODIES |
| MODIFIED HUMANISED ANTI-INTERLEUKIN-18 ANTIBODIES |